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Synopsis 
Thesis Titled: 
Role of RNAmprotein interactions in the internal initiation of translation of plus- 
strand RNA viruses: A novel target for antiviral therapeutics 
Internal initiation of translation is fundamentally different from the general cap- 
dependent scanning mechanism of translation of eukaryotic mRNAs. In this mode o f  
translation initiation, the ribosome i s  directly recruited to a site within the 5'-untranslated 
region of the mRNA, referred to as the Internal Ribosome Entry Site (IRES), and can initiate 
translation at the next downstream AUG codon. Ribosome binding to the IRES is mediated 
by a n~~rnber of cellular proteins, which include some canonical eukaryotic initiation factors 
(eIFs) together with other cellular trans-acting factors. In this thesis the role of RNA-protein 
interactions in the IRES-mediated translation o f  positive-strand RNA viruses has been 
investigated and a novel approach to inhibit viral IRES-mediated translation by targeting 
specific RNA-pro tein interactions has been demonstrated. 
In the first part o f  this thesis, the human La autoantigen, a cellular protein recognized 
by sera from patients with systemic lupus disease, was demonstrated to bind to the IRES o f  
coxsackievirus B3 (CVB 3), a picornavin~s that causes viral myocarditis in humans. La 
protein was found to stimulate CVB3 IRES-mediated translation and sequestration o f  La 
protein resulted in the inhibition of translation. Pancreatic tissue, a primary target organ for 
CVB3 infection, was found to have a large abundance o f  La protein, which was demonstrated 
to interact with the CVB3 IRES. Exogenous addition o f  pancreas cytoplasmic extract to in 
vitro translation reactions resulted in a dose-dependent stimulation o f  CVB3 IRES-mediated 
translation. Similarly, a human pancreatic cell line was found to support a high level o f  
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cleavage product of PTB in certain murine cells and it had been mapped to the C-teminai 
RRMs 3 and 4 o f  PTB. A polypeptide corresponding to RRMs 3 and 4 o f  PTB was over- 
expressed in eukaryotic cells and this resulted in the down-regulation of HAV IRES- 
mediated translation. This demonstrated that if the interaction of the viral IRES RNA with 
specific cellular proteins required for internal initiation of translation was antagonized, it 
could result in the inhibition of viral IRES-mediated translation. It also suggested that 
specific RNA-protein interactions could be targeted to selectively inhibit viral RNA 
translation in order to develop a novel approach to antiviral therapy. 
Therefore, in the third part o f  the thesis, the MA-protein interactions involved in the 
IRES-mediated translation o f  hepatitis C virus (HCV) was selectively targeted in order to 
inhibit HCV lRES activity. HCV, which causes chronic viral hepatitis leading to 
hepatocellular carcinoma, is a major human pathogen with an estimated 170 million chronic 
carriers throughout the world. Current treatment modalities have limited efficacy- and no 
vaccines are available. Therefore the development o f  novel antiviral strategies against HCV 
i s  the need of the hour. Moreover, the RNA-protein interactions involved in HCV IRES- 
mediated translation are well characterized and are therefore appropriate for targeting using 
specific inhibitor molecules. The HCV IRES consists o f  extensive RNA secondary structures 
that act as the binding site for a number of cellular proteins and the 40s ribosomal subunit. It 
was investigated whether small RNA molecules corresponding to the different stem-loop 
(SL) domains of the HCV IRES, when introduced in trans, could antagonize the binding o f  
cellular proteins to the viral IRES, thereby inhibiting HCV IRES-mediated translation. A 
small: RNA corresponding to the domain I11 o f  the HCV IRES was demonstrated to bind to a 
majority o f  cellular proteins interacting with the HCV IRES and was found to strongly inhibit 
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HCV IRES-mediated translation without significantly inhibiting cap-dependent translation. A 
smaller molecule corresponding to the SL I11 e+f subdomain inhibited HCV IRES-mediated 
translation even more efficiently and selectively. The SL I11 e+f RNA strongly interacted 
with ribosomal protein S5, which has been demonstrated to bind to the HCV IRES. It 
prevented the recruitment o f  the 40s ribosomal subunit by the HCV IRES but not by a 
capped rnRNA. It was also found that the SL I11 e+f RNA could directly bind to the 40s 
ribosomal subunit. This suggested that the SL I11 e+f RNA prevented the interaction of the 
40s subunit to the HCV IRES by interacting with a protein that established an important 
contact between the 40s subunit and the IRES RNA, thereby inhibiting translation initiation. 
These observations constit~~ted the "proof of concept" that small RNA molecules analogous 
to stem-loop structures o f  the HCV IRES could be used to selectively inhibit HCV IRES- 
mediated translation and provide a basis for the development o f  novel antiviral therapeutics. 
This thesis demonstrates that the interactions between viral IRES RNA and host 
trans-acting factors play a crucial role in mediating internal initiation of translation and can 
provide novel targets for developing antiviral therapeutics which would selectively inhibit 
viral IRES-mediated translation. 
